Market Insights

A recent Nature Communications study reports a breakthrough nanobody NB5 that specifically binds and activates the HCN4 channel extracellularly. It offers a new therapy for cardiac pacemaking dysfunction and uncovers a non-canonical gating mechanism that revises traditional HCN channel understanding.